Homocysteine and other biochemical parameters in Type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy

被引:68
|
作者
Huang, EJ
Kuo, WW
Chen, YJ
Chen, TH
Chang, MH
Lu, MC
Tzang, BS
Hsu, HH
Huang, CY
Lee, SD [1 ]
机构
[1] Cent Taiwan Univ Sci & Technol, Ctr Gen Educ, Taichung 406, Taiwan
[2] Dacha Lees Gen Hosp, Dept Surg, Dacha, Taiwan
[3] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan
[4] St Josephs Hosp, Endocrine Clin, Taichung, Taiwan
[5] Natl Chung Hsing Univ, Grad Inst Vet Publ Hlth, Taichung 40227, Taiwan
[6] Armed Force Taichung Gen Hosp, Div Cardiol, Taichung, Taiwan
[7] Chung Shan Med Univ, Dept Internal Med, Taichung, Taiwan
[8] Chung Shan Med Univ, Dept Microbiol & Immunol, Taichung, Taiwan
[9] Chung Shan Med Univ, Inst Biochem, Taichung, Taiwan
[10] Mackay Mem Hosp, Div Colorectal Surg, Taipei, Taiwan
[11] Chung Shan Med Univ, Coll Med Sci, Sch Phys Therapy, Taichung 40203, Taiwan
关键词
NIDDM; hyperhomocysteinemia; lactate dehydrogenase; retinopathy;
D O I
10.1016/j.cca.2005.10.025
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Cardiovascular risk-related markers in type 2 diabetes mellitus (DM) have not been well understood. Methods: Serum and urine samples for biochemical and immunologic analysis were collected from 204 normal subjects and 257 type 2 DM patients, the latter of which were further classified by different diabetic duration with or without retinopathy. Results: Glycosylated hemoglobin Ale, triglyceride, lipase, free fatty acid, albumin creatinine ratio (ACR), lactate dehydrogenase (LDH) and homocysteine were significantly increased in DM patients, whereas high density lipoprotein cholesterol and bilirubin were significantly decreased in DM patients, compared with normal subjects. Lipid profiles, ACR, bilirubin, uric acid, creatine kinase, and hsCPP were not changed in DM patients with different diabetic duration or diabetic retinopathy. Lactate dehydrogenase in DM patients with duration > 20 years and homocysteine in patients with duration > 10 years was significantly higher than those with duration > 5 years. Homocysteine was significantly increased in DM patients with retinopathy, compared with DM patients without retinopathy. Conclusion: The increased triglyceride, lipase, free fatty acid, albumin creatinine ratio, lactate dehydrogenase and homocysteine as well as decreased high density lipoprotein cholesterol and anti-oxidative bilirubin in DM patients should be cautious and considered as risks for increasing DM complication. Homocysteine might be associated with longer diabetic duration and microvascular complication of retinopathy in diabetes. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:293 / 298
页数:6
相关论文
共 50 条
  • [31] Results of screening for diabetic retinopathy in people with diabetes mellitus type 2 in Uzbekistan
    Ibraghimova, N. S.
    Normatova, N. M.
    Shagazatova, B. H.
    Yuldasheva, N. M.
    Berdykulova, D. M.
    DIABETOLOGIA, 2009, 52 : S433 - S433
  • [32] Corneal endothelial changes in type 2 diabetes mellitus relative to diabetic retinopathy
    Durukan, Irfan
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2020, 103 (04) : 474 - 478
  • [33] PREVALENCE OF DIABETIC RETINOPATHY IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
    Esteves, Jorge F.
    Kramer, Caroline K.
    de Azevedo, Mirela Jobim
    Stolz, Andressa P.
    Roggia, Murilo F.
    Larangeira, Andreia
    Miozzo, Suellen A.
    Rosa, Carolina
    Lambert, Jose Humberto
    Pecis, Miriam
    Rodrigues, Ticiana C.
    Santos Canani, Luis Henrique
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2009, 55 (03): : 268 - 273
  • [34] Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2
    Chatziralli I.P.
    Sergentanis T.N.
    Keryttopoulos P.
    Vatkalis N.
    Agorastos A.
    Papazisis L.
    BMC Research Notes, 3 (1)
  • [35] Lipoprotein(a) predicts development of diabetic retinopathy in patients with type 2 diabetes mellitus
    Ahn, Y. -B.
    Lim, T. -S.
    Yun, J. -S.
    Cha, S. -A.
    Seok, H.
    Moon, S. -D.
    Ko, S. -H.
    DIABETOLOGIA, 2015, 58 : S520 - S520
  • [36] Gut mycobiomes are altered in people with type 2 Diabetes Mellitus and Diabetic Retinopathy
    Jayasudha, Rajagopalaboopathi
    Das, Taraprasad
    Kalyana Chakravarthy, Sama
    Sai Prashanthi, Gumpili
    Bhargava, Archana
    Tyagi, Mudit
    Rani, Padmaja Kumari
    Pappuru, Rajeev Reddy
    Shivaji, Sisinthy
    PLOS ONE, 2020, 15 (12):
  • [37] Visual motion sensitivity as an indicator of diabetic retinopathy in type 2 diabetes mellitus
    Zhang, Tianlin
    Ying, Haojiang
    Wang, Huiqun
    Zhao, Fouxi
    Pan, Qiying
    Zhan, Qingqing
    Zhang, Fuyan
    An, Qinyu
    Liu, Tao
    Hu, Yuandong
    Zhang, Yang
    FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [38] Awareness of diabetic retinopathy among patients with type 2 diabetes mellitus in Jordan
    Bakkar, May M.
    Haddad, Mera F.
    Gammoh, Yazan S.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2017, 10 : 435 - 441
  • [39] Factors Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes Mellitus
    He, Bin-Bin
    Wei, Li
    Gu, Yun-Juan
    Han, Jun-Feng
    Li, Ming
    Liu, Yu-Xiang
    Bao, Yu-Qian
    Jia, Wei-Ping
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2012, 2012
  • [40] Lipoprotein(a) predicts the development of diabetic retinopathy in people with type 2 diabetes mellitus
    Yun, Jae-Seung
    Lim, Tae-Seok
    Cha, Seon-Ah
    Ahn, Yu-Bae
    Song, Ki-Ho
    Choi, Jin A.
    Kwon, Jinwoo
    Jee, Donghyun
    Cho, Yang Kyung
    Park, Yong-Moon
    Ko, Seung-Hyun
    JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (02) : 426 - 433